A lysosomal surveillance response to stress extends healthspan.

Publication date: Jun 26, 2025

Lysosomes are cytoplasmic organelles central for the degradation of macromolecules to maintain cellular homoeostasis and health. However, how lysosomal activity can be boosted to counteract ageing and ageing-related diseases remains elusive. Here we reveal that silencing specific vacuolar H-ATPase subunits (for example, vha-6), which are essential for intestinal lumen acidification in Caenorhabditis elegans, extends lifespan by ~60%. This longevity phenotype can be explained by an adaptive transcriptional response typified by induction of a set of transcripts involved in lysosomal function and proteolysis, which we termed the lysosomal surveillance response (LySR). LySR activation is characterized by boosted lysosomal activity and enhanced clearance of protein aggregates in worm models of Alzheimer’s disease, Huntington’s disease and amyotrophic lateral sclerosis, thereby improving fitness. The GATA transcription factor ELT-2 governs the LySR programme and its associated beneficial effects. Activating the LySR pathway may therefore represent an attractive mechanism to reduce proteotoxicity and, as such, potentially extend healthspan.

Open Access PDF

Concepts Keywords
Amyotrophic Activity
Atpase Ageing
Healthspan Boosted
Longevity Central
Worm Cytoplasmic
Degradation
Extends
Healthspan
Lysosomal
Lysosomes
Lysr
Macromolecules
Organelles
Stress
Surveillance

Semantics

Type Source Name
disease MESH Alzheimer’s disease
disease MESH Huntington’s disease
disease MESH amyotrophic lateral sclerosis
pathway KEGG Amyotrophic lateral sclerosis
pathway KEGG Lysosome
disease MESH live births
pathway REACTOME Metabolism
disease MESH Metabolic Diseases
pathway KEGG Metabolic pathways
drug DRUGBANK L-Cysteine
drug DRUGBANK Serine
drug DRUGBANK Phencyclidine
pathway REACTOME Autophagy
drug DRUGBANK L-Aspartic Acid
disease MESH shock
disease MESH Parkinson’s disease
drug DRUGBANK Sirolimus
drug DRUGBANK Adenosine phosphate
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
drug DRUGBANK Pidolic Acid
drug DRUGBANK Proline

Original Article

(Visited 12 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *